Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach-Reference-Cited by-同舟云学术

Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach

Published:2018-04-03 Issue:25 Volume:9 Page:17951-17970
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mangano Katia¹,Mazzon Emanuela²,Basile Maria Sofia¹,Di Marco Roberto³,Bramanti Placido²,Mammana Santa²,Petralia Maria Cristina¹⁴,Fagone Paolo¹,Nicoletti Ferdinando¹

Affiliation:

1. Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy

2. IRCCS Centro Neurolesi “Bonino-Pulejo”, Messina, Italy

3. Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy

4. Department of Formative Processes, University of Catania, Catania, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Host derived macrophage migration inhibitory factor expression attenuates anti-tumoral immune cell accumulation and promotes immunosuppression in the tumor microenvironment of head and neck squamous cell carcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

2. MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy;Cancers;2024-05-04

3. Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities;International Journal of Molecular Sciences;2024-04-29

4. MIF contribution to progressive brain diseases;Journal of Neuroinflammation;2024-01-04

5. Macrophage migration inhibitory factor as a therapeutic target in neuro-oncology: A review;Neuro-Oncology Advances;2024-01-01